Developmental and epileptic encephalopathy 27 is a rare disorder that usually begins in infancy or early childhood. It causes seizures and can affect development, learning, movement, and behavior over time. For some, the early symptoms of Developmental and epileptic encephalopathy 27 may be frequent seizures or missed developmental milestones. Not everyone will have the same experience, but this condition is usually long term and may be severe in some children, with a higher risk of complications related to hard-to-control epilepsy. Treatment focuses on seizure medicines and supportive care such as physical, occupational, speech, and developmental therapies.
How many people live with Developmental and epileptic encephalopathy 27?
Developmental and epileptic encephalopathy 27 is so rare that no reliable estimate is available for how many people are living with it worldwide or in the United States. Published medical sources describe it as an ultra-rare genetic form of epilepsy, but they do not give a consistent global count or a separate U.S. count for this specific type.
Overview
Developmental and epileptic encephalopathy 27Symptoms
Developmental and epileptic encephalopathy 27 often causes seizures, delayed development, and low muscle tone. Many children have trouble learning, speaking, or walking. Early symptoms of developmental and epileptic encephalopathy 27 usually begin in infancy.
Outlook and prognosis
Developmental and epileptic encephalopathy 27 often brings lifelong seizures and developmental challenges. Outlook varies widely, but many living with DEE27 need ongoing support with learning, movement, and daily care. Early seizure control and therapy can improve day-to-day function.
Causes and risk factors
Developmental and epileptic encephalopathy 27 is caused by a harmful change in the GRIN2B gene, usually arising new in the child and less often inherited from a parent. Risk is mainly genetic, while illness, fever, sleep loss, or stress can worsen seizures or symptoms.
Genetic influences
Genetics are central to Developmental and epileptic encephalopathy 27. It is caused by harmful changes in a single gene, so genetic testing is often key to confirming the diagnosis and helping families understand recurrence risk.
Diagnosis
Developmental and epileptic encephalopathy 27 is diagnosed using clinical features, EEG and brain imaging, then confirmed with genetic tests. The genetic diagnosis of Developmental and epileptic encephalopathy 27 helps explain seizures, developmental delay, and related findings.
Treatment and drugs
Treatment for Developmental and epileptic encephalopathy 27 focuses on seizure control with anti-seizure medicines, sometimes a ketogenic diet, and supportive therapies. Many also need feeding, movement, learning, and regular neurologic care as needs change.
Symptoms
Developmental and epileptic encephalopathy 27 often affects everyday milestones early, with seizures and slower progress in movement, speech, and learning. Many children also have differences in muscle tone, balance, behavior, or feeding, which can make daily routines more tiring. The early features of Developmental and epileptic encephalopathy 27 are often noticed in infancy or early childhood, but the pattern can look different from one child to another. Features vary from person to person and can change over time.
In Developmental and epileptic encephalopathy 27, seizures are a common feature. They can look like staring spells, stiffening, jerking, or sudden loss of awareness, and some are easy to miss at first.
Sitting, crawling, walking, and other milestones may come later than expected. Many children with Developmental and epileptic encephalopathy 27 also need extra support with learning and everyday skills.
Speech and language are often affected, with first words coming late or not developing fully. Some children understand more than they can say and may rely on gestures, pictures, or communication devices.
Low muscle tone can make a baby feel floppy and can make it harder to hold up the head, sit, or stay steady. For many children, this also makes feeding and longer periods of activity more tiring.
How people usually first notice Developmental and epileptic encephalopathy 27?
Developmental and epileptic encephalopathy 27 is usually first noticed in infancy, often when a baby begins having frequent seizures very early in life and is not developing as expected. Families and doctors may also notice low muscle tone, feeding problems, unusual stiffness or floppiness, and delays in skills such as holding up the head, rolling, or making early social responses. Because the first signs of developmental and epileptic encephalopathy 27 can overlap with other serious seizure disorders, the diagnosis is often considered after early neurologic evaluation, an electroencephalogram, and genetic testing.
Types of Developmental and epileptic encephalopathy 27
No distinct types of Developmental and epileptic encephalopathy 27 are widely recognized.
Can I slow down the onset of symptoms?
Probably not. For developmental and epileptic encephalopathy 27, symptoms are usually driven by an underlying gene change and often begin very early in life, so there is no good evidence that lifestyle changes like diet, exercise, sleep habits, or vitamins can meaningfully delay when symptoms start or prevent the condition. Early follow-up with a neurology team may help manage seizures and support development once symptoms appear, and while research is ongoing, it is best to be hopeful but realistic about what can and cannot change onset.
What genetics can tell you about symptoms
In developmental and epileptic encephalopathy 27, genetics can give some clues about symptoms because this condition is usually linked to changes in the GRIN2B gene, and different changes in that gene can affect how strongly brain signaling is disrupted. This can influence which features show up, such as seizures, developmental delay, low muscle tone, movement differences, or autism-like behaviors, as well as how early symptoms begin and how severe they are. Even so, genetics cannot predict everything, and people with the same condition can still have quite different day-to-day symptoms and support needs.
Causes and risk factors
The main genetic cause of developmental and epileptic encephalopathy 27 is a harmful change in the GRIN2B gene, which helps brain cells send signals. This change is often new in the child, but in some families it can be inherited from a parent. Risk can vary widely from person to person. The exact gene change, other genes, and differences in brain development can affect how severe the seizures and learning problems are. There are no known lifestyle or environmental causes, but illness, fever, poor sleep, or missed seizure medicine can make seizures more likely.
What are the most common causes or risk factors?
Developmental and epileptic encephalopathy 27 is usually caused by a harmful change in the GRIN2B gene, which helps brain cells send signals to each other. In many families, this gene change happens for the first time in the child rather than being passed down from a parent, although inherited cases can happen. There are no well-established lifestyle, diet, or environmental risk factors that commonly cause this condition.
Environmental and biological risk factors
Because the early symptoms of Developmental and epileptic encephalopathy 27 can resemble other brain conditions, families often ask what increases the chance of it happening. For this rare condition, most known risk relates to biological events before birth, and clear environmental causes have not been confirmed. Awareness of both biological and environmental influences helps you feel prepared.
Most cases of Developmental and epileptic encephalopathy 27 seem to begin with a biological change that happens around conception or very early in pregnancy. This usually appears without warning and often in families with no similar history.
In rare conditions caused by new biological changes, older paternal age can slightly raise the chance that one of these changes occurs during sperm formation. This is a small population-level effect, and most children of older fathers do not develop the condition.
No specific environmental exposure has been firmly proven to cause Developmental and epileptic encephalopathy 27. Researchers are still exploring how outside influences interact with our inner biology, but current evidence points much more strongly to early biological events than to external triggers.
Maternal illness, infections, or birth complications are not established causes of Developmental and epileptic encephalopathy 27. Doctors may still review these factors because other brain conditions can cause similar early symptoms.
Genetic risk factors
When families ask about the genetic causes of developmental and epileptic encephalopathy 27, the main answer is a harmful change in the GRIN2B gene. Some risk factors are inherited through our genes. Most cases happen as a new genetic change in the child, but a smaller number are passed down from a parent or linked to parental mosaicism, where the change is present in only some cells.
GRIN2B change: Developmental and epileptic encephalopathy 27 is caused by a harmful change in GRIN2B, a gene that helps brain cells communicate. Different changes in this gene can disturb signaling in different ways, which may affect how severe the condition is.
New variant: In many children, the GRIN2B change is new, meaning it happened for the first time in that child and was not inherited from either parent. This helps explain why many living with developmental and epileptic encephalopathy 27 have no family history of the condition.
Inherited pattern: A smaller number of people inherit the GRIN2B change from a parent in an autosomal dominant pattern, which means one altered copy can be enough to cause the condition. If a parent carries the variant, each pregnancy has a 50% chance of passing it on.
Parental mosaicism: Sometimes a parent has the GRIN2B change in only some cells, including egg or sperm cells, and may have few or no symptoms. This is called mosaicism, and it can raise the chance of having another child with developmental and epileptic encephalopathy 27 even when the parent's blood test is normal.
Lifestyle risk factors
Developmental and epileptic encephalopathy 27 is not caused by lifestyle habits, but daily routines and exposures can influence seizure control, development, safety, and overall functioning. In this condition, how lifestyle affects Developmental and epileptic encephalopathy 27 often depends on whether certain habits make seizures, fatigue, or missed therapies more likely. The most important factors are the ones that change brain stress, medication consistency, nutrition, sleep, and injury risk.
Missed sleep, irregular bedtimes, or poor-quality sleep can lower the seizure threshold and make breakthrough seizures more likely. A predictable sleep routine may support steadier seizure control and daytime alertness.
Skipped doses, late doses, or inconsistent medication routines can quickly worsen seizure control in Developmental and epileptic encephalopathy 27. Using structured schedules, reminders, and caregiver supervision may reduce avoidable seizure flares.
Viral infections, dehydration, and fever can stress the brain and trigger more seizures or longer recovery periods. Good hydration, prompt fever management, and early medical guidance during illness can help limit complications.
Inadequate calorie intake, feeding difficulties, or unbalanced meals can worsen low energy, growth problems, and recovery after seizures. When swallowing or feeding is difficult, nutrition support can directly affect strength, development, and resilience.
Risk prevention
For families affected by Developmental and epileptic encephalopathy 27, true prevention of the condition itself is usually not possible because it is a genetic disorder present from early life. Prevention is mainly about lowering the risk of seizures, injuries, illness-related setbacks, and other complications that can make day-to-day life harder. Different people need different prevention strategies—there’s no single formula. Early specialist care can make a meaningful difference in comfort, safety, and development.
If Developmental and epileptic encephalopathy 27 has been diagnosed in a child or runs in a family, genetic counseling can help clarify recurrence risk for future pregnancies. It can also explain testing options for relatives or during pregnancy in a clear, practical way.
Taking seizure medicines exactly as prescribed is one of the main ways to reduce complications from Developmental and epileptic encephalopathy 27. Regular follow-up with a neurology team helps adjust treatment if seizures change, cluster, or break through.
Missed sleep, illness, fever, flashing lights in some children, or missed medicines can make seizures more likely. Healthy routines are like safety belts: simple, everyday habits that offer protection.
Infections can worsen seizures and recovery in many living with Developmental and epileptic encephalopathy 27. Staying up to date on vaccines, treating fevers promptly, and having a plan for sick days may help prevent setbacks.
Can you prevent Developmental and epileptic encephalopathy 27?
No, developmental and epileptic encephalopathy 27 cannot usually be prevented, because it is caused by a gene change that is present from very early in life. If this condition runs in a family or a child has already been diagnosed, genetic counseling may help parents understand the chances in a future pregnancy, but it cannot guarantee prevention.
Transmission
Developmental and epileptic encephalopathy 27 is not an infection, so it is not contagious and cannot be passed from one person to another through touch, coughing, saliva, food, or sex. For many families, this means there is no risk of "catching" it in everyday life.
Instead, how Developmental and epileptic encephalopathy 27 is inherited depends on a gene change present from conception. In many living with Developmental and epileptic encephalopathy 27, that change happens for the first time in the child and is not inherited from either parent, although in some families it can be passed down from a parent who carries the same genetic change.
When to test your genes
Consider genetic testing as soon as a baby or child has unexplained early-onset seizures, developmental delay, or a pattern suggesting developmental and epileptic encephalopathy. A confirmed diagnosis can help guide treatment choices, avoid less useful tests, and clarify recurrence risk for future pregnancies.
Diagnosis
Developmental and epileptic encephalopathy 27 is usually suspected when a child has early seizures along with slowed development, changes in muscle tone, or problems with movement and learning. Doctors look at the overall pattern of symptoms and exam findings, then use brain and genetic tests to confirm the cause. Getting a diagnosis is often a turning point toward answers and support.
Doctors begin by reviewing when seizures started, how development has changed, and whether feeding, movement, or muscle tone problems are also present. The pattern of early symptoms can raise suspicion for the diagnosis of Developmental and epileptic encephalopathy 27.
A detailed exam looks for low muscle tone, stiffness, coordination problems, unusual movements, and differences in reflexes. These clinical features help show how the brain and nervous system are being affected.
An electroencephalogram, or EEG, records the brain's electrical activity and looks for seizure patterns linked with epileptic encephalopathy. It can help confirm that seizures are part of the condition, even when events are brief or hard to describe.
Brain imaging is often done to look for structural changes and to rule out other causes of seizures and developmental delay. MRI findings may be normal in some children, but the scan is still useful as part of the workup.
How is Developmental and epileptic encephalopathy 27 diagnosed?
Doctors usually diagnose developmental and epileptic encephalopathy 27 by looking at the full picture, including when seizures started, how they look, how a child is developing, and whether any skills have been lost. Common tests include an EEG, which records the brain’s electrical activity, a brain MRI scan to look for structural changes, and sometimes blood or urine tests to rule out other causes. Genetic testing often helps confirm the diagnosis by finding the gene change linked to this condition.
Stages of Developmental and epileptic encephalopathy 27
Developmental and epileptic encephalopathy 27 does not have defined progression stages. This is because it is usually understood as a lifelong neurodevelopmental condition with seizures and developmental differences, rather than an illness that moves through clear step-by-step phases over time. Often the process begins when you notice changes in daily life, such as seizures starting in infancy or early childhood, delays in sitting, walking, or speech, or periods when skills are hard to gain. Doctors usually diagnose and monitor Developmental and epileptic encephalopathy 27 by reviewing the early symptoms of Developmental and epileptic encephalopathy 27, examining development and seizure patterns, and using tests such as an EEG, brain imaging, and genetic testing.
Outlook and prognosis
The outlook for developmental and epileptic encephalopathy 27 is highly variable, but many affected children have persistent seizures together with lasting developmental, cognitive, speech, and motor impairment. In some people, seizures become easier to control over time, while in others they remain frequent or resistant to treatment, which can further affect learning, behavior, and daily function. Overall prognosis is shaped by the age seizures begin, how well they respond to therapy, and the severity of the underlying neurologic features. Most individuals require long-term multidisciplinary care and significant support, and independent adult living is often limited in more severely affected cases. Precise life expectancy data for developmental and epileptic encephalopathy 27 are not well defined, but mortality can be increased in severe epileptic encephalopathies because of complications such as status epilepticus, accidents, infections, and sudden unexpected death in epilepsy. Early seizure management, developmental therapies, and careful monitoring for complications may improve quality of life even when the condition remains chronic.
Long-term effects
For many living with developmental and epileptic encephalopathy 27, the long-term picture depends a lot on how severe the seizures and developmental differences are over time. Many continue to have lifelong effects on learning, movement, behavior, and day-to-day independence, although the pattern can vary widely from one person to another. The same challenges that first appear as early symptoms of developmental and epileptic encephalopathy 27 may continue into adolescence and adulthood, while other features become clearer with age. Long-term effects vary widely, and some people have more complex medical needs than others.
Seizures may remain frequent or hard to fully control over many years. For many, this can affect safety, schooling, sleep, and overall brain function.
Many people with developmental and epileptic encephalopathy 27 have lasting delays in speech, learning, and problem-solving. These differences often begin in infancy or childhood and can continue into adult life.
Low muscle tone, poor coordination, stiffness, or an unsteady walk can remain long term. Some may need help with sitting, walking, or fine motor tasks like feeding and dressing.
Spoken language may stay very limited, and some people communicate mainly through sounds, gestures, or assistive devices. This can make it harder to express pain, needs, or emotions clearly.
How is it to live with Developmental and epileptic encephalopathy 27?
Living with developmental and epileptic encephalopathy 27 often means coping with frequent seizures alongside major challenges in learning, communication, movement, and day-to-day independence. For many people with this condition, daily life revolves around close supervision, regular medicines and therapy appointments, and extra help with eating, mobility, sleep, and safety, although the exact pattern can vary from one child to another. This can also shape the lives of parents, siblings, and other caregivers, who may need to provide constant care, manage emergencies, and adjust work, school, and family routines, yet many families build strong support systems and find ways to create meaningful routines and connection.
Treatment and drugs
Developmental and epileptic encephalopathy 27 is usually treated by focusing on seizure control and on support for development, since both the epilepsy and the brain effects can affect daily life. Treatment often looks different for each person, but many living with Developmental and epileptic encephalopathy 27 may be offered anti-seizure medicines, and some may also need therapies such as physical, occupational, speech, or feeding support. If seizures are hard to control, a neurologist may adjust medicines over time and, in some cases, consider options such as a special high-fat diet used for epilepsy or other specialist treatments. Because this condition is genetic and can vary from child to child, care is often tailored to symptoms rather than one single standard drug plan.
Can you cure Developmental and epileptic encephalopathy 27?
No, there is not currently a cure for developmental and epileptic encephalopathy 27, a rare brain condition that causes seizures and affects development. Treatment aims to reduce seizures and support day-to-day needs such as learning, movement, feeding, and behavior. Medicines and supportive therapies can help many people living with this condition, but they do not take away the underlying cause.
Non-drug treatment
Day-to-day care for people with Developmental and epileptic encephalopathy 27 usually centers on therapies that support movement, communication, learning, feeding, and safety. Because this condition often begins early in life and can affect many parts of development, care is usually tailored to a child’s needs rather than using one fixed program. Supportive therapies can improve comfort, participation, and family routines, even when they do not stop the underlying condition. Not every approach works the same way, so families often adjust the plan over time.
Physical therapy can help with strength, balance, joint flexibility, and everyday movement such as sitting, standing, or walking. For many living with Developmental and epileptic encephalopathy 27, this may also help prevent stiffness and make transfers or positioning safer.
Occupational therapy focuses on hand use, play, dressing, seating, and other daily activities. It can also suggest adaptive tools or home changes that make routines easier and safer.
Speech and language therapy can help with communication, even for children who are not speaking with words. This may include gestures, picture boards, or speech devices, which can be especially important when early symptoms of Developmental and epileptic encephalopathy 27 include delays in communication.
Feeding and swallowing therapy can help if meals are slow, tiring, or linked to coughing and choking. Some children also benefit from guidance on food textures, safer positioning, and ways to support nutrition and hydration.
Your genes may have an impact on how drugs work for you
For people living with developmental and epileptic encephalopathy 27, the exact genetic change can affect how well seizure medicines work, so one medicine may help a lot while another may do very little or even make seizures or side effects worse. In day-to-day life, this can mean that finding the right treatment takes careful trial and follow-up, especially if seizures keep happening or a child seems unusually sleepy, irritable, or less alert on a medicine. Genetic test results can sometimes help guide these choices, but they usually do not predict the perfect treatment on their own, so doctors still need to watch symptoms closely and adjust the plan over time.
Pharmacological treatments
For many living with developmental and epileptic encephalopathy 27, treatment is mainly about reducing seizures and making day-to-day life safer and more predictable. There is no single medicine proven to treat the underlying cause of developmental and epileptic encephalopathy 27 in everyone, so doctors usually choose antiseizure drugs based on seizure type, age, and how well a child tolerates them. It’s common to try more than one drug before the best fit becomes clear. Medicines are often adjusted over time, especially if early symptoms of developmental and epileptic encephalopathy 27 include changing seizure patterns.
Levetiracetam is often used because it works across several seizure types and is available in forms that are easier for children to take. Doctors watch for sleepiness, irritability, or behavior changes, since these can matter as much as seizure control.
Valproate is a broad-spectrum antiseizure medicine that may help when seizures are varied or hard to classify. It can affect the liver, platelets, and weight, so blood tests and careful follow-up are often needed.
Clobazam, and sometimes clonazepam, may be added when seizures continue despite a first medicine. These drugs can be helpful, but drowsiness, drooling, and tolerance over time can limit how well they work.
Topiramate or lamotrigine may be considered when a child needs another long-term seizure medicine. Not everyone responds to the same medication in the same way, and each has its own side effect pattern such as sleepiness, appetite changes, or rash.
Genetic influences
For families living with seizures, developmental delays, and learning or movement challenges, it can be helpful to know that developmental and epileptic encephalopathy 27 is a genetic condition. This specific form is caused by a disease-causing change in the GRIN2B gene, and one altered copy of this gene is enough to cause DEE27. GRIN2B helps brain cells communicate, so when it is not working normally, brain signaling can become disrupted in ways that affect both development and seizures. Many people with developmental and epileptic encephalopathy 27 have a new GRIN2B change that happened for the first time in them, although the condition can sometimes be passed down from a parent. Even with the same gene change, people can have different seizure patterns, developmental progress, and support needs. Genetic testing for developmental and epileptic encephalopathy 27 can confirm the cause and help families understand the chance of it happening again in a future pregnancy.
Is Developmental and epileptic encephalopathy 27 genetic?
Genetics are central to Developmental and epileptic encephalopathy 27. It is caused by harmful changes in a single gene, so genetic testing is often key to confirming the diagnosis and helping families understand recurrence risk.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of being human and are common throughout the general population. Most of these changes do not directly affect health and simply reflect natural human diversity. For many genes, carrying a change associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-understood change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When seizures keep breaking through or a medicine causes too much sleepiness, the exact gene change behind Developmental and epileptic encephalopathy 27 can help doctors make more informed treatment choices. Not every difference in response is genetic, but in Developmental and epileptic encephalopathy 27, the genetic result can give clues about which anti-seizure medicines are more likely to help, which ones may be less useful, and when other supports should be added early. For many living with Developmental and epileptic encephalopathy 27, this means care is usually personalized rather than based on a single standard drug plan.
Genetic testing for Developmental and epileptic encephalopathy 27 can also confirm that the condition is part of a genetic epilepsy syndrome, which may help families understand why treatment can involve some trial and adjustment over time. Even with the same gene pattern, people can respond differently, so doctors still look at seizure type, age, side effects, and development when choosing medicine. At this point, treatment is mainly aimed at controlling seizures and supporting development, rather than correcting the underlying genetic change itself.
Interactions with other conditions
Day to day, people with developmental and epileptic encephalopathy 27 often deal with more than seizures alone, and other health problems can make symptoms harder to manage. Common coexisting issues can include feeding and swallowing difficulties, sleep problems, movement changes, and repeated chest infections, especially if swallowing is not safe. Doctors call it a comorbidity when two conditions occur together, and in developmental and epileptic encephalopathy 27 these added problems may raise the risk of seizure flare-ups, missed nutrition, or more hospital visits. For example, a simple viral illness with fever may trigger more seizures, while poor sleep can leave someone more irritable, less alert, or slower to recover afterward. Many living with developmental and epileptic encephalopathy 27 also need care from several specialists because epilepsy, development, breathing, and nutrition can affect each other at the same time. This is why treatment usually works best when the whole picture is reviewed together, rather than focusing only on the seizures or only on the other illness.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Developmental and epileptic encephalopathy 27?
Other severe seizure disorders that start in babies or young children, such as Dravet syndrome, Lennox-Gastaut syndrome, and infantile spasms, can look similar because they may also cause hard-to-control seizures along with slow development or loss of skills. Brain problems present from birth, brain injury, and some rare metabolic conditions can also cause a similar mix of seizures and developmental concerns, so doctors usually use genetic testing, brain scans, and other checks to tell them apart.
History
Many living with developmental and epileptic encephalopathy 27 first come to medical attention because seizures begin early in life and development does not follow the usual path. Families may notice that a baby or young child is missing milestones, seems unusually floppy or stiff, or has repeated spells that are hard to explain at first. These day-to-day concerns shaped how doctors began recognizing this condition as part of a broader group of severe childhood epilepsies.
Initially understood only through symptoms, later developmental and epileptic encephalopathy 27 was separated more clearly from other causes of early seizures and developmental delay. As brain imaging, EEG testing, and genetic testing improved, doctors became better at seeing that children with similar early symptoms could have different underlying conditions. That mattered because the early symptoms of developmental and epileptic encephalopathy 27 can overlap with several other epilepsy-related disorders, especially in infancy and early childhood.
In recent decades, awareness has grown as researchers linked this condition to a genetic cause and refined the way it is classified. Developmental and epileptic encephalopathy 27 is now understood as one specific form within the developmental and epileptic encephalopathies, a group in which seizures and the underlying brain disorder can both affect learning and development. Not every child follows exactly the same course, but this clearer understanding has helped families get a more accurate diagnosis, better counseling, and care that fits the child’s needs more closely.